Investigating the NKG2A pathway to treat hair loss in alopecia areata
Targeting the NKG2A Pathway in Alopecia Areata
This study is looking at alopecia areata, a condition that causes hair loss, and is exploring new ways to help by targeting certain immune cells; if you're dealing with this condition, you might have a chance to join trials testing these exciting new treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11051236 on NIH RePORTER |
What this research studies
This research focuses on alopecia areata, a chronic autoimmune condition that leads to hair loss. The team has identified specific immune cells that contribute to the disease and is exploring how targeting the NKG2A pathway can help regulate these cells. By using advanced techniques like single-cell RNA sequencing, they aim to understand the immune response better and develop new treatment strategies. Patients may have the opportunity to participate in trials that test these innovative therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alopecia areata who are experiencing hair loss.
Not a fit: Patients with other forms of hair loss not related to autoimmune conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, effective treatments for patients suffering from alopecia areata.
How similar studies have performed: Previous research has shown promise in targeting immune pathways for autoimmune conditions, suggesting potential success for this approach.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Christiano, Angela M — Columbia University Health Sciences
- Study coordinator: Christiano, Angela M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.